Attached files
| file | filename |
|---|---|
| EX-32 - EX-32.1 - CERUS CORP | cers-ex32_10.htm |
| EX-31 - EX-31.2 - CERUS CORP | cers-ex31_9.htm |
| EX-31 - EX-31.1 - CERUS CORP | cers-ex31_6.htm |
| EX-10 - EX-10.4 - CERUS CORP | cers-ex10_217.htm |
| EX-10 - EX-10.2 - CERUS CORP | cers-ex10_218.htm |
| 10-Q - FORM 10-Q - CERUS CORP | cers-10q_20170331.htm |
Exhibit 10.1
2016 and 2017 Executive Officer Compensation Arrangements
The compensation for the executive officers of Cerus Corporation regarding annual base salaries and target bonus percentages were as follows:
|
Name |
2016 Annual Base |
2016 Targeted Bonus (as a % of 2015 Annual Base |
2017 Annual Base |
2017 Targeted Bonus (as a % of 2016 Annual Base |
|
Salary (1) |
Salary) |
Salary (1) |
Salary) |
|
|
William M. Greenman President and Chief Executive Officer |
$ 580,000 |
60% |
$ 600,000 |
60% |
|
Kevin D. Green |
$ 353,600 |
40% |
$ 371,280 |
40% |
|
Vice President, Finance and Chief Financial Officer |
|
|
|
|
|
Richard J. Benjamin MBChB, PhD, FRCPath |
$ 385,700 |
40% |
$ 401,128 |
40% |
|
Chief Medical Officer |
|
|
|
|
|
Laurence M. Corash, M.D. |
$ 414,100 |
40% |
$ 422,382 |
40% |
|
Senior Vice President, Chief Scientific Officer |
|
|
|
|
|
Vivek Jayaraman |
$ 400,000 |
40% |
$ 404,000 |
40% |
|
Chief Commercial Officer |
|
|
|
|
|
Chrystal N. Menard |
$ 343,200 |
40% |
$ 377,520 |
40% |
|
Chief Legal Officer and General Counsel |
|
|
|
|
|
Carol Moore |
$ 339,552 |
40% |
$ 346,343 |
40% |
|
Senior Vice President, Regulatory Affairs, Quality and Clinical |
|
|
|
|
|
|
|
|
|
|
|
(1) Annual base salary was effective March 1. |
|
|
|
|